Search filters

List of works by Judith A. M. Wessels

A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis

article

A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?

scientific article published on 30 July 2011

An n-of-one RCT for intravenous immunoglobulin G for inflammation in hereditary neuropathy with liability to pressure palsy (HNPP)

scientific article published on 17 July 2015

Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.

scientific article

CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease

scientific article published on December 2009

Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure

scientific article published in July 2012

Comment on: Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate

scientific article published on 13 July 2009

Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo.

scientific article published in March 2002

Criteria for the selection of single nucleotide polymorphisms in pathway pharmacogenetics: TNF inhibitors as a case study

scientific article published on 12 June 2009

Differences in 5-hydroxytryptamine-3B haplotype frequencies between Asians and Caucasians.

scientific article

Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus

scientific article published on November 2010

Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.

scientific article published on April 2006

Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose

article

Exploratory analysis of 1936 SNPs in ADME genes for association with busulfan clearance in adult hematopoietic stem cell recipients.

scientific article

Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients

scientific article published on 01 February 2007

Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients

scientific article published on 10 May 2016

Gene-gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis

scientific article published in December 2009

Genetic markers of treatment response in rheumatoid arthritis

scientific article published on October 2006

Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinib

scientific article published on 19 November 2010

Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment

scientific article published on 01 August 2011

Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib

scientific article

Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases

scientific article published on 12 May 2011

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data

scientific article

Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity

scientific article published on 10 September 2009

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors

scientific article

Pharmacogenetics of tomorrow: the 1 + 1 = 3 principle

scientific article published in July 2010

Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis

scientific article published on 01 September 2006

SNPs and haplotypes in DPYD and outcome of capecitabine--Letter

scientific article published on 30 August 2011

Validation of the acenocoumarol EU-PACT algorithms: similar performance in the Rotterdam Study cohort as in the original study

scientific article published in August 2012

Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction

scientific article published on 29 August 2012